A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?

Purpose: The oligometastatic state is a proposed entity between localized cancer and widely metastatic disease, comprising an intermediate subset of metastatic cancer patients. Most data to support locally-directed treatment, such as stereotactic ablative radiotherapy (SABR), for oligometastases are...

Full description

Bibliographic Details
Main Authors: Faiez Al-Shafa, Andrew J. Arifin, George B. Rodrigues, David A. Palma, Alexander V. Louie
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Oncology
Subjects:
stereotactic
radiotherapy
SBRT
SABR
oligometastasis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00543/full

Similar Items

Similar Items